Scientists in the East of England have developed a way of using artificial intelligence to check for skin cancer, with the AI tool outperforming existing methods in a new study.
2025
Melanoma tumors thicker than 0.8 mm increase risk for death
The crude incidence rate of melanoma-related death 20 years after diagnosis was 6% for those with tumors thinner than 0.8 mm.
Nivolumab/Ipilimumab Continues to Show Survival Benefit in Melanoma
The CheckMate 067 trial found that, at a 10-year follow-up, nivolumab/ipilimumab elicited a median OS of 71.9 months in patients with previously untreated, advanced melanoma.
Tumor Upstaging in Invasive Melanoma Linked to Worse Survival Outcomes
Shortfalls in clinical management may explain why tumor upstaging in invasive melanoma is associated with worse survival outcomes, according to study findings published in the Journal of the American Academy of Dermatology.